Skip to Main Content
Wexler Boley & Elgersma LLP
  • Our Firm
    • Who We Serve
      • Shareholders
      • Whistleblowers
      • Consumers
      • Businesses
      • Government Entities
    • Our Professionals
    • Working with Wexler Boley & Elgersma LLP
    • Locations
    • News
    • Careers
    • Report Your Concern
    • Testimonials
  • Practice Areas
    • Antitrust Litigation
    • Business & Commercial Litigation
    • Securities & Corporate Governance
    • Healthcare Litigation
    • Consumer Protection
    • Whistle Blower False Claims Litigation
    • Government Representation
    • Employment Litigation
  • Cases
    • Antitrust Litigation Cases
    • Business & Commercial Litigation Cases
    • Consumer Protection Cases
    • Employment Litigation Cases
    • Government Representation Cases
    • Healthcare Litigation Cases
    • Mass Tort Litigation Cases
    • Securities & Corporate Governance Cases
    • Whistle Blower False Claims Cases
  • Investigations
    • Similac Toxic Infant Formula Lawsuit
    • Kid’s Castle Biometric Privacy Lawsuit
    • Contaminated Baby Food Lawsuit
    • Fatal Sportmix Pet Food Recall Class Action Lawsuit
    • Claire’s Data Breach Lawsuit
    • Insurance Denial for Mental Health and Substance Abuse Treatment
    • Perpetual Sales Litigation
    • Railroad Price-Fixing Lawsuit
    • Medicare Advantage Fraud Litigation
    • Biometric Fingerprinting Litigation
  • Blog
  • Contact Us
See all blog posts
11.23.2010

FDA’s Negligence of Painkillers’ Side Effects Could Have Caused over 1,000 Deaths

By Ji Sook Yim, Editor
Hall Of Shame, In The News, Villain Of The Week, You Should Know, For Consumers

Last Friday, national consumer advocacy group Public Citizen criticized FDA’s negligence about the dangerous side effects of Darvon.

Public Citizen first petitioned FDA for a recall of these painkillers in 1978 and again in 2006 after receiving concerns about the drug’s dangerous side effects. Evidence showed that risks outweighed the limited benefits. Darvon was shown to cause addiction and lead to toxin build-up in the heart. After FDA’s failure to act on the petition to pull the drugs from the market, Public Citizen filed a lawsuit against FDA in 2008.

The FDA did not recall the painkillers until last week, claiming that the agency didn’t receive enough evidence to justify the risks of these drugs until recently. FDA received data the the drugs were associated with heart arrhythmia, which could cause death. The UK banned Darvon and Darvocet in 2005 and Europe banned the drugs a year ago. Public Citizen believes FDA’s delay in recalling the drugs have caused over 1,000-2000 deaths in the US since the ban in the UK.

Darvon has been around for more than 50 years, and since its first introduction to the US in 1957, it has been used as a painkiller for post-surgical pain. More than 22 million people have been prescribed Darvocet, which is currently the most popular form of Darvon.

Dr. Sidney Wolfe, director of Public Citizen’s health research wing, stated that Public Citizen will try to start up an investigation to determine the responsible figures behind FDA’s delay in taking the painkillers off the market. In the meanwhile, product liability lawyers will be looking into the Darvon and Darvocet lawsuits for patients who have suffered injuries from the drugs.

According to Wolfe, the FDA “needed to order a human study to find that ‘the drug puts patients at risk of potentially serious or even fatal heart rhythm abnormalities’ before deciding whether to ban [the drugs].” It’s mind-boggling to believe that FDA would neglect the serious consequences of these drugs for so many years when there have already been tens of thousands of cases of deaths and near-death. Sure, it is true that all pain medications have dangerous side effects, but is 50 years too long of a wait to realize the seriousness of the complications that arise from the drugs?

Source: Darvon, Darvocet Side Effects Needed Earlier Recall: Public Citizen

Photo Credit: Charles Williams

Share

Comments (1)

  • 8.23.2012
    Alison says:

    The FDA reviews a lot of data and rruqiees strong evidence before they will approve a drug for sale, but sometimes negative evidence does not become available until long after a drug is on the market. Some of these drugs may have been on the market for years, if not decades, and were grandfathered into an approved status and remained on the market until further data could be presented that was strong enough to support FDA taking action. This is the case with Darvon, Darvocet or propoxyphene- containing compounds. Propoxyphene is a drug that we, as consulting pharmacists, have known for a long time has risks that outweigh its benefits. That is why following the advice of a well-trained pharmacist is critical since there are other drugs on the market that we caution against using or that should be monitored more closely. Thanks again for your comments.

    Reply

Leave a Reply Cancel reply

Receive News Updates

Get the latest from Wexler Wallace LLP & stay informed.

Categories

  • Media Appearances
  • Uncategorized
  • Columns
    • Guest Post
    • Ken Wexler
    • Ed Wallace
  • Practice Areas
    • Consumer Protection
    • Mass Tort Litigation
    • Business & Commercial Litigation
    • Healthcare Litigation
    • Employment Litigation
  • Cases
  • Hall Of Shame
    • Villain Of The Week
  • In The News
    • Public Victories
  • Featured Investigations
  • The Firm
    • News releases
    • Around The World
    • Our Professionals
    • Chicago
  • You Should Know
    • For Investors
    • For Businesses
    • For Consumers
  • Featured Cases
  • awards
  • Facebook
  • Twitter
  • LinkedIn
Image

311 S. Wacker Drive,
Suite 5450
Chicago, IL 60606
P_312.346.2222
F_312.346.0022

  • Our Firm
  • Practice Areas
  • Cases
  • Investigations
  • Newsroom
  • Blog
  • Contact Us
  • Sitemap
  • Privacy Statement
  • Legal Disclaimer

2022 © Wexler Boley & Elgersma LLP